AzTrials
AzTrials

Comparing Six Different Methods to Obtain Expiratory Time ConstantNCT05827640

Expiratory Time Constant in Mechanically Ventilated Patients

An observational study of Comparing Six Different Methods to Obtain Expiratory Time Constant, run by East Slovak Institute for Cardiovascular Diseases at 1 site in Slovakia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Determining expiratory time constants in mechanically ventilated patients Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
data recording using conventional ventilation strategies (PCV and VCV)
How many people
30 participants
Where
1 siteSlovakia
Study dates
15 Nov 2022to 30 Jan 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients undergoing elective cardiac surgery with extracorporeal circulation (mostly CABG or AVR).

Who may be able to join

None listed.

Who cannot join

  • known pulmonary disease
  • previous thoracic surgery
  • poor preoperative cardiac status

Trial locations and contacts

1 site in 1 country.

Slovakia1 site
  • East Slovak Institute for Cardiovascular Diseases

    Košice, 040 01

Other trials in Slovakia

About this study

Official title: Determining Expiratory Time Constant in Mechanically Ventilated Patients

Determining expiratory time constants in mechanically ventilated patients

Read the detailed description

Adult patients (n = 30) undergoing elective cardiac surgery with extracorporeal circulation (ECC) were included. Patients were excluded from the study if they had any known lung disease or had previous thoracic surgery. After the surgery, all patients were transferred to the intensive care unit (ICU) and connected to well-established Servo-U (Maquet, Getinge AB, Solna, Sweden) mechanical ventilator. First, the ventilation mode was set to mandatory volume-controlled ventilation (VCV) for 15 minutes. After that, mandatory pressure-controlled ventilation (PCV) for another 15 minutes was commenced. All patients were in supine position, sedated and paralyzed using continuous infusion of propofol and atracurium with no spontaneous breathing efforts. During VCV, an end-inspiratory pause (TPAUSE 10%) has been added to obtain inspiratory plateau pressure (P PLAT) under static conditions. Respiratory variables in VCV for all patients were as follows: PEEP 6 - 9 cmH 2 O depending on the local protocol, protective tidal volume (Vt) of 7 ml/kg/PBW, T PAUSE was set to 10%, I:E ratio of 1:2, rise time 5% and the respiratory rate was 14 breaths/min. After 15 minutes, VCV was changed to PCV with the same ventilator setting with inspiratory pressure set in the way to best match the Vt during the VCV. ARDSNet tables were used to determine PBW for all patients.

A novel device enabling data acquisition (Dr. Wave, Quadrus Medical Technologies, NY, White Plains, USA) has been connected to the Servo-U ventilator after admission to the ICU to record flow, pressure, and volume waveforms. All data in the study were derived from measurements and calculations from this device and included: Peak Inspiratory Pressure (PIP), PPLAT, PEEP, expiratory tidal volume (Vt) respiratory system compliance (C RS ), airway resistance (RTOT) and the peak expiratory flow rate (PEFR).

Based on obtained data of flow, volume and pressure during PCV and VCV, six different methods to determined expiratory time constant were examined

Being tested
data recording using conventional ventilation strategies (PCV and VCV)
Keywords
expiratory time constant, mechanical ventilation, exhalation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • data recording using conventional ventilation strategies (PCV and VCV)Other

    no intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Expiratory time constant

    Six different methods to assess expiratory time constants in mechanically ventilated patients

    Measured: 3 months

Secondary outcomes (1)
  1. Validity of expiratory time constant definition

    To prove if three time constant correspond to actual first time constant multiplied by the factor of 3

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2023
  2. Study start15 Nov 2022
  3. Primary completion30 Jan 2023
  4. Study completion30 Jan 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05827640
Sponsor's protocol ID
www.vusch.sk
Status last verified
Apr 2023
First submitted
12 Apr 2023
Last updated
25 Apr 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Comparing Six Different Methods to Obtain Expiratory Time Constant, run by East Slovak Institute for Cardiovascular Diseases at 1 site in Slovakia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 0 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 25 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Slovakia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Expiratory time constant (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in